Skip to search boxSkip to navigationSkip to main content

Bibliometric Analysis of Research Between Deep Brain Stimulation and Alzheimer’s Disease

  • Miguel Cabanillas-Lazo
    ,
  • Carlos Quispe-Vicuña
    ,
  • Fran Espinoza-Carhuancho
    ,
  • Frank Mayta-Tovalino(corresponding author)
*Corresponding author for this work
  • Universidad de Huánuco
    ,
  • Universidad Científica del Sur
    ,
  • Universidad San Ignacio de Loyola
Research Output:
Contribution to journal
Article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 458-467 (10 pages)

Journal (Volume, Issue Number)

International Journal of Nutrition, Pharmacology, Neurological Diseases (Volume 14, Issue 4)

Publication milestones

  • Published - 01/10/2024

Publication status

Published - 01/10/2024

ISSN

2231-0738

Publication IDs

  • Scopus: 85208401694

Abstract

Objective: To examine the thematic evolution and scientific productivity of the relationship between deep brain stimulation (DBS) and Alzheimer’s disease (AD). Materials and methods: A descriptive study using a scientometric approach was conducted using the Scopus database between 2019 and July 2024. Data were exported to the SciVal bibliometric analysis tool, and bibliometric indicators, such as number of publications per country/region, citations per publication, and h-index, were used. Results: A total of 150 publications were obtained, mostly of high quality (Q1) and coming from the USA and China. Lozano was the most productive author, and the University of Toronto in Canada had the highest number of publications. The journal with the highest impact was Frontiers in Neuroscience with 21.3 citations/paper, and most authors only published one article. Conclusions: The bibliometric study revealed decreasing research trends but mostly highlighted large international collaborations, especially in high-impact journals. The findings can serve as a basis for future research and policies evaluating the impact of DBS in the management of patients with AD.